Regeneron shares near $300 as earnings report emboldens investors

... reach somewhere between $1.35 billion and $1.38 billion, up from its previous forecast of $1.2 to $1.3 billion. Tarrytown, N.Y.-based Eylea said net income for the quarter was $141.3 million, or $1.25 a share, compared with $191.5 million, or $1.72 ...

http://blogs.marketwatch.com/health-exchange/2013/11/05/regeneron-shares-near-300-as-earnings-report-emboldens-investors/?mod=MW_home_latest_news